SCHEMBL3768142

SCHEMBL3768142

C=CCN1CCC(c2cccc(Cl)c2F)CC1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ADRA2A P08913 1/20 0.48
ADRA2B P18089 1/20 0.48
ADRA2C P18825 1/20 0.48
SIGMAR1 Q99720 1/20 0.42
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
HTR1A P08908 3/20 0.39
ADRA1B P35368 1/20 0.39
OPRM1 P35372 1/20 0.37
OPRK1 P41145 1/20 0.37
OPRL1 P41146 1/20 0.37
DRD3 P35462 2/20 0.37
KCNH2 Q12809 1/20 0.37
DRD2 P14416 3/20 0.36
DRD1 P21728 2/20 0.36
DRD5 P21918 2/20 0.36
MAPK10 P53779 1/20 0.36
SLC6A4 P31645 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5509179 0.94 ADRA2A (0.43) ADRA2AADRA2BADRA2CSIGMAR1MEN1
SCHEMBL5503801 0.89 DRD2 (0.46) ADRA2AADRA2BADRA2CDRD3DRD2
SCHEMBL3766106 0.86 SIGMAR1 (0.44) ADRA2AADRA2BADRA2CSIGMAR1HTR1A
SCHEMBL3759932 0.86 ADRA2A (0.54) ADRA2AADRA2BADRA2CSIGMAR1MEN1
SCHEMBL5506480 0.84 DRD2 (0.42) ADRA2AADRA2BADRA2CDRD3DRD2
SCHEMBL3774468 0.83 OPRL1 (0.43) ADRA2AADRA2BADRA2CSIGMAR1OPRL1
SCHEMBL2783386 0.83 ADRA2A (0.48) ADRA2AADRA2BADRA2CSIGMAR1MEN1
SCHEMBL3764528 0.83 ADRA2A (0.48) ADRA2AADRA2BADRA2CSIGMAR1MEN1
SCHEMBL2785541 0.83 ADRA2A (0.48) ADRA2AADRA2BADRA2CSIGMAR1MEN1
SCHEMBL2782554 0.83 ADRA2A (0.45) ADRA2AADRA2BADRA2CSIGMAR1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7851629-B2 Disubstituted phenylpiperidines as modulators of dopamine and serotonin neurotransmission NSAB, FILIAL AF NEUROSEARCH SWEDEN AB, SVERIGE (DK) 2010-12-14 US claimed
EP-1768958-B1 NEW DISUBSTITUTED PHENYLPIPERIDINES AS MODULATORS OF DOPAMINE AND SEROTONIN NEUROTRANSMISSION NSAB AF NEUROSEARCH SWEDEN AB (DK) 2009-11-18 EP claimed
US-20070179185-A1 NEW DISUBSTITUTED PHENYLPIPERIDINES AS MODULATORS OF DOPAMINE AND SEROTONIN NEUROTRANSMISSION NSAB, FILIAL AF NEUROSEARCH SWEDEN AB, SVERIGE (DK) 2007-08-02 US claimed
US-7851629-B2 Disubstituted phenylpiperidines as modulators of dopamine and serotonin neurotransmission NSAB, FILIAL AF NEUROSEARCH SWEDEN AB, SVERIGE (DK) 2010-12-14 US disclosed
EP-1768958-B1 NEW DISUBSTITUTED PHENYLPIPERIDINES AS MODULATORS OF DOPAMINE AND SEROTONIN NEUROTRANSMISSION NSAB AF NEUROSEARCH SWEDEN AB (DK) 2009-11-18 EP disclosed
US-20070179185-A1 NEW DISUBSTITUTED PHENYLPIPERIDINES AS MODULATORS OF DOPAMINE AND SEROTONIN NEUROTRANSMISSION NSAB, FILIAL AF NEUROSEARCH SWEDEN AB, SVERIGE (DK) 2007-08-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070179185-A1 NEW DISUBSTITUTED PHENYLPIPERIDINES AS MODULATORS OF DOPAMINE AND SEROTONIN NEUROTRANSMISSION DRD2, DRD4, HTR4 ADRA2A 49/4885ADRA2B 78/4885ADRA2C 36/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.